[
  {
    "ts": "2025-10-07T10:14:31+00:00",
    "headline": "Venture financing for mRNA-based vaccines declines 82% in 2025 YTD",
    "summary": "Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.",
    "url": "https://www.pharmaceutical-technology.com/analyst-comment/venture-financing-mrna-vaccines-declines-2025-ytd/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "d86472f5-c1b9-325c-8460-51272dd07000",
      "content": {
        "id": "d86472f5-c1b9-325c-8460-51272dd07000",
        "contentType": "STORY",
        "title": "Venture financing for mRNA-based vaccines declines 82% in 2025 YTD",
        "description": "",
        "summary": "Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.",
        "pubDate": "2025-10-07T10:14:31Z",
        "displayTime": "2025-10-07T10:14:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/bdec833d64a6739bb287a7d415e29bb2",
          "originalWidth": 989,
          "originalHeight": 464,
          "caption": "Credit: GlobalData.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9t4BapL_1aSF5J0cCoGo.w--~B/aD00NjQ7dz05ODk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/bdec833d64a6739bb287a7d415e29bb2.cf.webp",
              "width": 989,
              "height": 464,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wKHMNtFD8CZusoOurXrg4A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/bdec833d64a6739bb287a7d415e29bb2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/analyst-comment/venture-financing-mrna-vaccines-declines-2025-ytd/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/venture-financing-mrna-based-vaccines-101431690.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DATA.L"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]